Literature DB >> 27621820

Compared lethality rates of Clostridium difficile infections at the local, regional and national levels in France.

M Huart1, C Abat2, M T Jimeno3, X Deparis4, D Raoult5, P-E Fournier6.   

Abstract

Entities:  

Year:  2016        PMID: 27621820      PMCID: PMC5009227          DOI: 10.1016/j.nmni.2016.07.006

Source DB:  PubMed          Journal:  New Microbes New Infect        ISSN: 2052-2975


× No keyword cloud information.
Dear Sir, In December 2013, we reported a Clostridium difficile (CD) outbreak caused by the hyper-virulent ribotype 027 in the Provence-Alpes-Côte d’Azur (PACA) area, southeastern France [1]. Sixty-one patients were hospitalized from March 2013 to April 2014 in the four university hospitals of Marseille (Timone, Conception, North and Sainte-Marguerite) for CD 027 infection, with a mortality of 43% [2]. Following this outbreak, we developed an automated epidemiological surveillance system for CD cases. Cloatridium difficile is associated with an elevated lethality worldwide [2], [3], [4]. This lethality has gradually increased, exceeding that of many other bacterial species. In the present retrospective study, from January 2012 to December 2015, we compared the lethality rates of CD isolated in enterocolitis and the three most common bacterial pathogens isolated from any specimen (Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa) in the university hospitals of Marseille, in the PACA area, France. The analysed data include the numbers of patients infected by each of the four above-mentioned bacterial species and the associated lethality for patients over 65 years old. The data at the Marseille and regional levels were obtained using our epidemiological surveillance system whereas national data were obtained by the medical information service in Timone hospital (National Data obtained by Convention de droit d’usage des données PMSI, N°d’agrément 2015-111111-88-46). Duplicates were removed. For a given patient, only the first infection caused by a given microorganism was registered. We calculated the annual lethality rates (for the years 2012 to 2015) by dividing the number of deaths by the number of patients affected by the respective bacterial species by each year. All data collection and descriptive epidemiological analyses were performed in Excel. Within Marseille university hospitals, we observed a stable lethality rate of E. coli urinary-tract infections between 2012 and 2015 (3.6%–5.6%, Table 1). For E. coli bacteraemia, the lethality increased from 2012 to 2014 (11.8%–18.3%, Table 1) and decreased in 2015 (10.7%). For S. aureus bacteraemia, the lethality decreased constantly from 22.9% in 2012 to 19.1% in 2014 (Table 1) then increased in 2015 (20.3%). For P. aeruginosa bacteraemia the lethality increased from 2012 (28.6%) to 2013 (31.7%), then decreased in 2014 (23.1%) and increased in 2015 (30.4%; Table 1). The CD lethality rate was lower in 2012 (10.6%) than in other years and reached a peak of 18.3% in 2013 (1.7-fold increase) and then decreased in 2014 (17.9%) and 2015 (12.4%).
Table 1

Number of deaths and lethality rate of infection caused by Clostridium difficile and the three most common bacterial pathogens in Marseille university Hospitals, Provence-Alpes-Côte d’Azur region and France from January 2012 to December 2015

Bacterial speciesMarseille University Hospitals
PACA Region
France
Numbera of patientsNumber of deathsLethality rateNumber of patientsNumber of deathsLethality rateNumber of patientsNumber of deathsLethality rate
2012
Global mortalityb30 89015815.1339 18219 0375.63 502 943215 9456.2
Clostridium difficile47510.65668615.27500128817.2
Escherichia coli bacteraemia1361611.8114629826.010 752257523.9
Escherichia coli UTI380215.58 5626888.097 35758916.1
Staphylococcus aureus bacteraemia1052422.966023836.18131253931.2
Pseudomonas aeruginosa bacteraemia28828.632413140.43028117638.8
2013
Global mortalityb31 72315835.0347 52019 2205.53 588 311215 3036.0
Clostridium difficile142*26*18.371014220.08461151117.9
Escherichia coli bacteraemia1332216.5120131326.111 574292325.3
Escherichia coli UTI478173.690236427.1103 74665496.3
Staphylococcus aureus bacteraemia1042120.268722232.37988266933.4
Pseudomonas aeruginosa bacteraemia411331.733312236.63155116837.0
2014
Global mortalityb32 33515594.8356 10819 4275.53 695 116216 7345.9
Clostridium difficile1482718.291417519.18883158017.8
Escherichia coli bacteraemia1973618.3136531022.713 069309523.7
Escherichia coli UTI534295.496797337.6110 56569396.3
Staphylococcus aureus bacteraemia1733319.177126934.98350277433.2
Pseudomonas aeruginosa bacteraemia521223.140412631.23325115834.8
2015
Global mortalityb32 55516455.1N/AN/AN/A3 836 118229 6086.0
Clostridium difficile153*19*12.4N/AN/AN/A11 336197217.4
Escherichia coli bacteraemia2422610.7N/AN/AN/A21 901415219.0
Escherichia coli UTI1 111625.6N/AN/AN/A114 96275076.5
Staphylococcus aureus bacteraemia1432920.3N/AN/AN/A11 481360831.4
Pseudomonas aeruginosa bacteraemia561730.4N/AN/AN/A4301148334.5

UTI, urinary tract infection.

*p 0.09, not significant.

National Data obtained by: Convention de droit d’usage des données PMSI, N°d’agrément 2015-111111-88-46.

Includes all causes of death, infectious or not.

At the PACA level, in 2012, 2013 and 2014, the lethality rate of CD infections was also lower than those of other pathogens (Table 1). At the country level, the highest lethality rate in 2012 and 2013 was that of P. aeruginosa, which was slightly higher than that of C. difficile. When considering the evolution of lethality rates over time (Table 1), we observed that CD-related mortality had the greatest variation among bacterial pathogens in Marseille and PACA, which may be explained by the 2013–2014 CD 027 outbreak [2]. We also observed a great reduction in CD-related lethality in 2015, although non-significant (two-sided Pearson’s chi-square test, p 0.09). This reduction followed the implementation of systematic faecal microbiota transplantation for patients hospitalized in Marseille university hospitals with CD 027 infections [2]. Together, these results confirmed that CD is a major life-threatening bacterial pathogen, especially for the elderly, like P. aeruginosa. This confirms what was previously observed in our region [1], [5] and also in northern France and other countries [6], [7]. The rapid decrease in the lethality of CD infections in Marseille university hospitals (18.3% to 12.4%) and the PACA region can be explained by the introduction of new treatment for all patients in PACA, the faecal microbiota transplantation [5]. Our study demonstrated that the CD-related lethality was similar in Marseille university hospitals and at the regional and national levels and was lower than those caused by P. aeruginosa or S. aureus. CD remains a major public health concern. Moreover, our results should encourage hospitals to extensively survey CD infections by the implementation of automatic monitoring systems, and also by developing rapid screening procedures to identify and isolate infected patients and healthy carriers upon hospitalization.
  6 in total

1.  Clostridium difficile 027 emerging outbreak in Marseille, France.

Authors:  Jean-Christophe Lagier; Gregory Dubourg; Nadim Cassir; Pierre-Edouard Fournier; Philippe Colson; Hervé Richet; Philippe Brouqui; Didier Raoult
Journal:  Infect Control Hosp Epidemiol       Date:  2013-12       Impact factor: 3.254

2.  Impact of ribotype 027 on Clostridium difficile infection in a geriatric department.

Authors:  G Mascart; M Delmée; J Van Broeck; E Cytryn; R Karmali; S Cherifi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-05       Impact factor: 3.267

3.  Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.

Authors:  J-C Lagier; M Delord; M Million; P Parola; A Stein; P Brouqui; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-07       Impact factor: 3.267

4.  Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

Authors:  E J Kuijper; F Barbut; J S Brazier; N Kleinkauf; T Eckmanns; M L Lambert; D Drudy; F Fitzpatrick; C Wiuff; D J Brown; J E Coia; H Pituch; P Reichert; J Even; J Mossong; A F Widmer; K E Olsen; F Allerberger; D W Notermans; M Delmée; B Coignard; M Wilcox; B Patel; R Frei; E Nagy; E Bouza; M Marin; T Akerlund; A Virolainen-Julkunen; O Lyytikäinen; S Kotila; A Ingebretsen; B Smyth; P Rooney; I R Poxton; D L Monnet
Journal:  Euro Surveill       Date:  2008-07-31

Review 5.  Current status of Clostridium difficile infection epidemiology.

Authors:  Fernanda C Lessa; Carolyn V Gould; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

Review 6.  Clostridium difficile infection: a worldwide disease.

Authors:  Kristin E Burke; J Thomas Lamont
Journal:  Gut Liver       Date:  2014-01-13       Impact factor: 4.519

  6 in total
  1 in total

1.  Implementation and Initial Analysis of a Laboratory-Based Weekly Biosurveillance System, Provence-Alpes-Côte d'Azur, France.

Authors:  Michael Huart; Gabriel Bedubourg; Cédric Abat; Philippe Colson; Jean Marc Rolain; Hervé Chaudet; Pierre Edouard Fournier; Didier Raoult; Xavier Deparis
Journal:  Emerg Infect Dis       Date:  2017-04       Impact factor: 6.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.